Telomeres are protective caps at the ends of chromosomes that shorten with each skin cell division. Telomere shortening leads to skin cell senescence and reduced regenerative capacity. As we age, the accumulation of senescent cells with critically short telomeres contributes to skin aging, characterized by wrinkles, thinning, and loss of elasticity. Maintaining healthy telomere length through lifestyle factors and potential therapeutic interventions helps preserve skin cell populations and delay the visible signs of aging. So you can use any skin cream you choose, but if you don't extend telomers, you are wasting your time. Check the video to learn more.

"Award Winning and Patented Revolutionary Skincare from TeloSkin". Best Seller! World first in dermal reprogramming. Learn our science by clicking here. Our mission is to revolutionize skincare by pioneering patented products that extend telomeres and inhibit the activity of interleukin 17, offering our customers a unique approach to combat aging. Welcome to biology based skincare.



Teloskin Pty Ltd
  • Since 2015

    Our team has been researching the primary drivers of skin aging and how to prevent it.

  • 100%

    All compounds used in Teloskin’s products are scientifically based, stability tested and made in the USA

  • TL17

    Prolong cellular populations by extending telomeres and inhibiting interleukin 17. Click Here to learn more

  • Science

    Teloskin’s lab tests numerous compounds in the fight against skin aging. Finally, solutions are here. Click Here for more

1 of 4
About Us

About Us

Our team has been working on skin creams that can extend telomeres for many years, with our first patent in telomere extending skin creams being submitted in 2019.

Learn More
  • Interleukin 17 (IL-17) is a cytokine that plays a key role in inflammation and immune responses.

  • The presence of IL-17 has been linked to various
    skin conditions, such as psoriasis and dermatitis,

1 of 2

Teloskin Award Winning Tech

Skin Care

Skin Care

Skin aging is a complex process influenced by both intrinsic and extrinsic factors. Telomere shortening and increased inflammation, particularly involving IL-17, have been identified as key contributors to skin aging (Smith et al., 2019). TL17 is a novel topical formulation designed to target these mechanisms by inhibiting telomere shortening and IL-17 activity. This study aimed to evaluate the efficacy of TL17 in improving signs of skin aging in women over 50 years old.

Read More